Divi's Laboratories

Divi's Laboratories Debt

The Debt of Divi's Laboratories (DIVISLAB.NS) as of Nov 12, 2026 is 40.00 M INR. In the previous year, Debt was 20.00 M INR — a change of 100.00% (higher).

Debt

40.00 MINR

YoY

100.00%

Last updated:

In 2025, Divi's Laboratories's total debt was 40.00 M INR, a 100.00% change from the 20.00 M INR total debt recorded in the previous year.

The Divi's Laboratories Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
631.10 M INR
Jan 1, 2019
1.06 B INR
Jan 1, 2020
381.00 M INR
Jan 1, 2021
40.40 M INR
Jan 1, 2022
28.70 M INR
Jan 1, 2023
27.70 M INR
Jan 1, 2024
20.00 M INR
Jan 1, 2025
40.00 M INR
The Divi's Laboratories Debt history
YEARDebtYoY
40.00 MINR+100.00%
20.00 MINR-27.80%
27.70 MINR-3.48%
28.70 MINR-28.96%
40.40 MINR-89.40%
381.00 MINR-63.92%
1.06 BINR+67.33%
631.10 MINR+76.58%
357.40 MINR-16.76%
429.38 MINR+55.17%
276.72 MINR+38.53%
199.75 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Divi's Laboratories Stock analysis

What does Divi's Laboratories do? Divi's Laboratories Ltd. is a pharmaceutical company based in Hyderabad, India. It was founded in 1990 and has become one of the leading manufacturers of active ingredients and formulations for the pharmaceutical industry in recent years. The company was founded by Dr. Murali Divi, who built the company on principles of quality, technology, and innovation. Divi's Laboratories now employs approximately 13,000 employees and operates production facilities in India and the USA. The company operates in various sectors, including generics, custom synthesis, research and development, and nutraceuticals. Its products are used worldwide and are approved in over 95 countries. Divi's Laboratories follows a vertically integrated supply chain model, producing high-quality active ingredients and developing its own formulations for the pharmaceutical industry. The company always relies on innovative technologies and continuous improvement of product quality. Its product range includes a wide range of active ingredients for various therapeutic areas, such as antibiotics, antidepressants, antihypertensives, antidiabetics, static lipid-lowering agents, and antipsychotics. Divi's Laboratories has state-of-the-art production facilities, strict quality controls, and advanced analytical facilities for all pharmaceutical ingredients. In addition to its active ingredients, the company is also known for its custom synthesis services, which involve the production of customer-specific active ingredients for the pharmaceutical industry. Divi's Laboratories offers a tailored service that meets the specific requirements of customers, ranging from the development of new active ingredients and formulations to the production of small or medium quantities of active ingredients. In the area of research and development, Divi's Laboratories works closely with academic institutions and other pharmaceutical companies to leverage the latest scientific knowledge and develop innovative products. The company invests a significant sum in research and development annually. In addition to active ingredients and custom synthesis services, Divi's Laboratories also offers a range of nutraceuticals. These products, such as vitamins, minerals, and other dietary supplements, are used to support a healthy lifestyle. In summary, Divi's Laboratories is an India-based pharmaceutical company specializing in the manufacture of active ingredients and formulations for the pharmaceutical industry. The company operates to the highest quality standards and relies on innovative technologies and sustainable product development. The wide product range and custom synthesis services offer customers a tailored solution for their needs. Divi's Laboratories is a leading provider of active ingredients and has made a name for itself in the pharmaceutical and nutraceutical industry due to its high quality and productivity. Divi's Laboratories is one of the most popular companies on Eulerpool.

Debt Details

Understanding Divi's Laboratories's Debt Structure

Divi's Laboratories's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Divi's Laboratories's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Divi's Laboratories’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Divi's Laboratories’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Divi's Laboratories stock

Debt of Divi's Laboratories is 40.00 M INR in 2025.

Debt of Divi's Laboratories changed from 20.00 M INR to 40.00 M INR, representing a 100.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Divi's Laboratories since 2006 – with annual values, charts, and detailed analysis.

Debt's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Divi's Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Divi's Laboratories

All Key Metrics — Divi's Laboratories